{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:29:27Z","timestamp":1790692167656,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"RD Lawrence Research Fellowship awarded by Diabetes UK"},{"name":"Ulster University Proof of Principle programme"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.peptides.2019.170233","type":"journal-article","created":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T11:03:27Z","timestamp":1578740607000},"page":"170233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Emerging role of GIP and related gut hormones in fertility and PCOS"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7196-7863","authenticated-orcid":false,"given":"R. Charlotte","family":"Moffett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violetta","family":"Naughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2019.170233_bib0005","series-title":"Fertility Problems: Assessment and Treatment (NICE Guideline CG156)","author":"National Institute for Health and Care Excellence","year":"2017"},{"issue":"6","key":"10.1016\/j.peptides.2019.170233_bib0010","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S1472-6483(10)61644-6","article-title":"PCOS: a diagnostic challenge","volume":"8","author":"Azziz","year":"2004","journal-title":"Reprod. Biomed. Online"},{"issue":"8","key":"10.1016\/j.peptides.2019.170233_bib0015","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1701-2163(16)32915-2","article-title":"Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies","volume":"30","author":"Lujan","year":"2008","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.peptides.2019.170233_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/719050","article-title":"Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth","volume":"2014","author":"Rojas","year":"2014","journal-title":"Int. J. Reprod. Med."},{"issue":"1","key":"10.1016\/j.peptides.2019.170233_bib0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12978-018-0519-2","article-title":"A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis","volume":"15","author":"Wu","year":"2018","journal-title":"Reprod. Health"},{"issue":"4","key":"10.1016\/j.peptides.2019.170233_bib0030","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.soard.2011.09.022","article-title":"Roux-en-Y gastric bypass ameliorates polycystic ovary syndrome and dramatically improves conception rates: a 9-year analysis","volume":"8","author":"Jamal","year":"2012","journal-title":"Surg. Obes. Relat. Dis."},{"key":"10.1016\/j.peptides.2019.170233_bib0035","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/01.sla.0000089851.41115.1b","article-title":"Effect of laparoscopic roux-en-Y gastric bypass on type II diabetes mellitus","volume":"238","author":"Schauer","year":"2003","journal-title":"Ann. Surg."},{"key":"10.1016\/j.peptides.2019.170233_bib0040","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1001\/jama.2008.641","article-title":"Pregnancy and fertility following bariatric surgery: a systematic review","volume":"300","author":"Maggard","year":"2008","journal-title":"JAMA."},{"issue":"11","key":"10.1016\/j.peptides.2019.170233_bib0045","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jamasurg.2016.2317","article-title":"Bariatric surgery and long-term durability of weight loss","volume":"151","author":"Maciejewski","year":"2016","journal-title":"JAMA Surg."},{"issue":"6","key":"10.1016\/j.peptides.2019.170233_bib0050","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2337\/dc16-0145","article-title":"Mechanisms of diabetes improvement following bariatric\/metabolic surgery","volume":"39","author":"Batterham","year":"2016","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.peptides.2019.170233_bib0055","doi-asserted-by":"crossref","first-page":"13600","DOI":"10.14814\/phy2.13600","article-title":"Effect of Roux-en-Y gastric bypass on liver mitochondrial dynamics in a rat model of obesity","volume":"6","author":"Sacks","year":"2018","journal-title":"Physiol. Rep."},{"issue":"4","key":"10.1016\/j.peptides.2019.170233_bib0060","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4103\/jmas.JMAS_5_17","article-title":"Impact of bariatric surgery on obstructive sleep apnoea-hypopnea syndrome in morbidly obese patients","volume":"13","author":"Priyadarshini","year":"2017","journal-title":"J. Minim. Access Surg."},{"key":"10.1016\/j.peptides.2019.170233_bib0065","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.peptides.2017.12.010","article-title":"Intestinal peptide changes after bariatric and minimally invasive surgery: relation to diabetes remission","volume":"100","author":"Gissey","year":"2018","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2019.170233_bib0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3132\/dvdr.2007.034","article-title":"Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP): evidence and clinical opportunity for development of new obesity-diabetes drugs?","volume":"4","author":"Flatt","year":"2007","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.peptides.2019.170233_bib0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1474651409103927","article-title":"Bariatric surgery to treat diabesity","volume":"9","author":"Flatt","year":"2009","journal-title":"Br. J. Diabetes Vasc. Dis."},{"key":"10.1016\/j.peptides.2019.170233_bib0080","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00125-009-1288-9","article-title":"Circadian rhythms of GIP and GLP-1 in glucose-tolerant and type 2 diabetic patients after bilio-pancreatic diversion","volume":"53","author":"Mingrone","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2019.170233_bib0085","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.peptides.2015.08.013","article-title":"The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones","volume":"77","author":"Meek","year":"2016","journal-title":"Peptides."},{"issue":"12","key":"10.1016\/j.peptides.2019.170233_bib0090","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1210\/jc.2005-1490","article-title":"The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery","volume":"90","author":"Escobar-Morreale","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2019.170233_bib0095","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/endo.135.3.8070381","article-title":"Gonadotropin-releasing hormone pulse frequency regulates expression of pituitary follistatin messenger ribonucleic acid: a mechanism for differential gonadotrope function","volume":"135","author":"Kirk","year":"1994","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.peptides.2019.170233_bib0100","first-page":"317","article-title":"Regulation of gonadotropin secretion: implications for polycystic ovary syndrome","volume":"20","author":"McCartney","year":"2002","journal-title":"J. Reprod. Med."},{"issue":"5","key":"10.1016\/j.peptides.2019.170233_bib0105","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1055\/s-2007-984741","article-title":"Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty","volume":"25","author":"Blank","year":"2007","journal-title":"Semin Reprod Med: The Hypothalamic-Pituitary Axis in Reproduction."},{"issue":"6","key":"10.1016\/j.peptides.2019.170233_bib0110","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1507\/endocrj.K09E-185","article-title":"GnRH pulsatility, the pituitary response and reproductive dysfunction","volume":"56","author":"Tsutsumi","year":"2009","journal-title":"Endocr. J."},{"issue":"1-3","key":"10.1016\/j.peptides.2019.170233_bib0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jsbmb.2009.12.010","article-title":"Insulin and hyperandrogenism in women with polycystic ovary syndrome","volume":"122","author":"Baptiste","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"5","key":"10.1016\/j.peptides.2019.170233_bib0120","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.peptides.2019.170233_bib0125","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3892\/etm.2017.4642","article-title":"Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: aggravated complication of pregnancy","volume":"14","author":"Yao","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.peptides.2019.170233_bib0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000471805","article-title":"High prevalence of polycystic ovary syndrome in type 1 diabetes mellitus adolescents: Is there a difference depending on the NIH and Rotterdam Criteria?","volume":"87","author":"Busiah","year":"2017","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.peptides.2019.170233_bib0135","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2337\/dc06-2574","article-title":"Fertility in women with type 1 diabetes","volume":"30","author":"Jonasson","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.peptides.2019.170233_bib0140","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1007\/s00125-014-3376-8","article-title":"Fertility is reduced in women and in men with type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium (T1DGC)","volume":"57","author":"Wiebe","year":"2014","journal-title":"Diabetologia."},{"key":"10.1016\/j.peptides.2019.170233_bib0145","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-4939-2895-8_5","article-title":"Regulation of glucose homeostasis by glucocorticoids","volume":"872","author":"Kuo","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.peptides.2019.170233_bib0150","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1210\/jc.2005-2222","article-title":"Genetic variation in 11\u03b2-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome","volume":"91","author":"Gambineri","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.peptides.2019.170233_bib0155","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/er.2012-1050","article-title":"11\u03b2-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspects","volume":"34","author":"Gathercole","year":"2013","journal-title":"Endocr. Rev."},{"issue":"8","key":"10.1016\/j.peptides.2019.170233_bib0160","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1210\/jc.2013-1385","article-title":"Ovarian 11[beta]-hydroxysteroid dehydrogenase (11[beta]HSD) activity is suppressed in women with anovulatory polycystic ovary syndrome (PCOS): apparent role for ovarian androgens","volume":"98","author":"Michael","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2019.170233_bib0165","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1210\/endo.141.2.7326","article-title":"Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling","volume":"141","author":"Maclusky","year":"2000","journal-title":"Endocrinology"},{"issue":"1-2","key":"10.1016\/j.peptides.2019.170233_bib0170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.2040-1124.2010.00022.x","article-title":"GIP and GLP-1, the two incretin hormones: similarities and differences","volume":"1","author":"Seino","year":"2010","journal-title":"J. Diabetes Investig."},{"issue":"6","key":"10.1016\/j.peptides.2019.170233_bib0175","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1210\/endo.133.6.8243312","article-title":"Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain","volume":"133","author":"Usdin","year":"1993","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.peptides.2019.170233_bib0180","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1210\/en.2004-0858","article-title":"Effects of polypeptide YY(3-36) upon luteinizing hormone-releasing hormone and gonadotropin secretion in prepubertal rats: in vivo and in vitro studies","volume":"146","author":"Fernandez-Fernandez","year":"2005","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.peptides.2019.170233_bib0185","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/frne.1996.0010","article-title":"Nutritional infertility: the role of the interconnected hypothalamic neuropeptide Y galanin- opioid network","volume":"17","author":"Kalra","year":"1996","journal-title":"Front. Neuroendocrinol."},{"issue":"5","key":"10.1016\/j.peptides.2019.170233_bib0190","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/humupd\/dml024","article-title":"Obesity and the role of gut and adipose hormones in female reproduction","volume":"12","author":"Gosman","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.peptides.2019.170233_bib0195","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.2174\/1381612822666160715143933","article-title":"Gut-brain axis and metabolism in polycystic ovary syndrome","volume":"22","author":"Saydam","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.peptides.2019.170233_bib0200","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/cen.12619","article-title":"Biomarkers and insulin sensitivity in women with polycystic ovary syndrome: characteristics and predictive capacity","volume":"83","author":"Cassar","year":"2015","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"4","key":"10.1016\/j.peptides.2019.170233_bib0205","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.beem.2009.03.001","article-title":"Therapeutic potential for GIP receptor agonists and antagonists","volume":"23","author":"Irwin","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2019.170233_bib0210","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/FBP.0b013e32833c8544","article-title":"Role of the glucose-dependent insulinotropic polypeptide and its receptor in the central nervous system: therapeutic potential in neurological diseases","volume":"21","author":"Figueiredo","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.peptides.2019.170233_bib0215","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bone.2016.07.014","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) dose-dependently reduces osteoclast differentiation and resorption","volume":"91","author":"Mabilleau","year":"2016","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.peptides.2019.170233_bib0220","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2337\/dc10-0704","article-title":"GIP: An inconsequential incretin or not?","volume":"33","author":"Pratley","year":"2010","journal-title":"Diabetes Care"},{"issue":"10160","key":"10.1016\/j.peptides.2019.170233_bib0225","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/S0140-6736(18)32260-8","article-title":"Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial","volume":"392","author":"Frias","year":"2018","journal-title":"Lancet."},{"issue":"7","key":"10.1016\/j.peptides.2019.170233_bib0230","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.2337\/db13-1563","article-title":"Chronic reduction of GIP secretion alleviates obesity and insulin resistance under high-fat diet conditions","volume":"63","author":"Nasteska","year":"2014","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.peptides.2019.170233_bib0235","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1210\/jc.2014-1180","article-title":"Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome","volume":"99","author":"Chang","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.peptides.2019.170233_bib0240","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1530\/EJE-08-0097","article-title":"Incretin levels in polycystic ovary syndrome","volume":"159","author":"Vrbikova","year":"2008","journal-title":"Eur. J. Endocrinol."},{"issue":"472","key":"10.1016\/j.peptides.2019.170233_bib0245","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1126\/scitranslmed.aat3392","article-title":"Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models","volume":"10","author":"Killion","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.peptides.2019.170233_bib0250","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1152\/ajpendo.00460.2007","article-title":"GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet","volume":"293","author":"McClean","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2019.170233_bib0255","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00125-015-3618-4","article-title":"GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial","volume":"58","author":"G\u00f6gebakan","year":"2015","journal-title":"Diabetologia."},{"issue":"2","key":"10.1016\/j.peptides.2019.170233_bib0260","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/db10-0902","article-title":"Glucose-dependent insulinotropic polypeptide reduces fat-specific expression and activity of 11\u03b2-hydroxysteroid dehydrogenase type 1 and inhibits release of free fatty acids","volume":"61","author":"G\u00f6gebakan","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2019.170233_bib0265","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/787201","article-title":"Differences in expression, content, and activity of 11\u03b2-HSD1 in adipose tissue between obese men and women","author":"Torres","year":"2012","journal-title":"ISRN Endocrinol."},{"key":"10.1016\/j.peptides.2019.170233_bib0270","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.metabol.2008.11.009","article-title":"Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin","volume":"58","author":"Svendsen","year":"2009","journal-title":"Metabolism"},{"issue":"12","key":"10.1016\/j.peptides.2019.170233_bib0275","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1210\/en.2013-1613","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 (11\u03b2-HSD1) inhibitors still improve metabolic phenotype in male 11\u03b2-HSD1 knockout mice suggesting off-target mechanisms","volume":"154","author":"Harno","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2019.170233_bib0280","first-page":"3330","article-title":"Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11\u03b2-hydroxysteroid dehydrogenase type 1 activity","volume":"87","author":"Rask","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.peptides.2019.170233_bib0285","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/EJE-13-1030","article-title":"Tissue-specific dysregulation of 11\u03b2-hydroxysteroid dehydrogenase type 1 in overweight\/obese women with polycystic ovary syndrome compared with weight-matched controls","volume":"171","author":"Gambineri","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.peptides.2019.170233_bib0290","first-page":"2006","article-title":"Differential expression of messenger ribonucleic acids encoding 11\u03b2-hydroxysteroid dehydrogenase types 1 and 2 in human granulosa cells","volume":"82","author":"Tetsuka","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2019.170233_bib0295","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1677\/joe.0.1780127","article-title":"Expression of 11\u03b2-hydroxysteroid dehydrogenase (11\u03b2HSD) proteins in luteinizing human granulosa-lutein cells","volume":"178","author":"Thurston","year":"2003","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.peptides.2019.170233_bib0300","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1530\/REP-07-0003","article-title":"Implication of cortisol and 11\u03b2-hydroxysteroid dehydrogenase (11\u03b2HSD) enzymes in the development of porcine (Sus scrofa domestica) ovarian follicles and cysts","volume":"133","author":"Sunak","year":"2007","journal-title":"Reproduction"},{"key":"10.1016\/j.peptides.2019.170233_bib0305","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jsbmb.2017.11.004","article-title":"Incretins modulate progesterone biosynthesis by regulating bone morphogenetic protein activity in rat granulosa cells","volume":"178","author":"Nishiyama","year":"2018","journal-title":"J. Steroid Biochem."},{"issue":"5","key":"10.1016\/j.peptides.2019.170233_bib0310","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.2337\/diabetes.53.5.1326","article-title":"Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors","volume":"53","author":"Hansotia","year":"2004","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.peptides.2019.170233_bib0315","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1210\/en.2016-1861","article-title":"Food intake affects sperm-egg fusion through the GIP\/PSG17 axis in mice","volume":"158","author":"Shimizu","year":"2017","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.peptides.2019.170233_bib0320","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0196-9781(99)00011-X","article-title":"Gastric inhibitory polypeptide stimulates glucocorticoid secretion in rats, acting through specific receptors coupled with the adenylate cyclase-dependent signalling pathway","volume":"20","author":"Mazzocchi","year":"1999","journal-title":"Peptides."},{"issue":"9","key":"10.1016\/j.peptides.2019.170233_bib0325","first-page":"3168","article-title":"Food-dependent Cushing\u2019s syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells","volume":"81","author":"de Herder","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.peptides.2019.170233_bib0330","first-page":"583","article-title":"Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing\u2019s syndrome: in Vivo and in Vitro Studies","volume":"86","author":"Tsagarakis","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2019.170233_bib0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110543","article-title":"Marked cortisol production by intracrine ACTH in GIP-treated cultured adrenal cells in which GIP receptor was exogenously introduced","volume":"9","author":"Fujii","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2019.170233_bib0340","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41574-018-0016-2","article-title":"Glucagon-like peptide 1 in health and disease","volume":"14","author":"Andersen","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"7","key":"10.1016\/j.peptides.2019.170233_bib0345","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2008-0115","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome","volume":"93","author":"Elkind-Hirsch","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.peptides.2019.170233_bib0350","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/EJE-13-0797","article-title":"Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin","volume":"170","author":"Jensterle","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.peptides.2019.170233_bib0355","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/obr.12720","article-title":"Pharmacologic therapy to induce weight loss in women who have obesity\/overweight with polycystic ovary syndrome: a systematic review and network meta\u2010analysis","volume":"19","author":"Wang","year":"2018","journal-title":"Obes. Rev."},{"key":"10.1016\/j.peptides.2019.170233_bib0360","first-page":"324","article-title":"Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.peptides.2019.170233_bib0365","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/1570161114666161221115324","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists in the treatment of obese women with polycystic ovary syndrome","volume":"15","author":"Tzotzas","year":"2017","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.peptides.2019.170233_bib0370","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1172\/JCI610","article-title":"Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line","volume":"15","author":"Beak","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2019.170233_bib0375","series-title":"The Study of GLP-1 Analogue in PI3K\/AKT\/FoxO1 Pathway in the Ovaries of Rats With Polycystic Ovary Syndrome","author":"Yang","year":"2016"},{"key":"10.1016\/j.peptides.2019.170233_bib0380","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1177\/1933719116635278","article-title":"Effects of exenatide on metabolic changes, sexual hormones, inflammatory cytokines, adipokines, and weight change in a DHEA-Treated rat model","volume":"23","author":"Sun","year":"2016","journal-title":"Reprod. Sci."},{"issue":"6","key":"10.1016\/j.peptides.2019.170233_bib0385","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/cen.13454","article-title":"Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight\/obese polycystic ovary syndrome","volume":"87","author":"Liu","year":"2017","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.peptides.2019.170233_bib0390","doi-asserted-by":"crossref","DOI":"10.1007\/s11695-019-04111-z","article-title":"Long-term modulation of appetitive hormones and sweet cravings after adjustable gastric banding and Roux-en-Y gastric Bypass","author":"Tsouristakis","year":"2019","journal-title":"Obes. Surg."},{"issue":"2","key":"10.1016\/j.peptides.2019.170233_bib0395","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neulet.2004.03.003","article-title":"Ghrelin effects on gonadotropin secretion in male and female rats","volume":"362","author":"Fern\u00e1ndez-Fernandez","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.peptides.2019.170233_bib0400","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1006\/bbrc.2001.5854","article-title":"Intracerebroventricular administration of ghrelin rapidly suppresses pulsatile luteinizing hormone secretion in ovariectomized rats","volume":"288","author":"Furuta","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2019.170233_bib0405","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000077271","article-title":"Ghrelin inhibits prolactin secretion in prepubertal rats","volume":"79","author":"Tena-Sempere","year":"2004","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.peptides.2019.170233_bib0410","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/endo.143.2.8646","article-title":"Novel expression and functional role of ghrelin in rat testis","volume":"143","author":"Tena-Sempere","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2019.170233_bib0415","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1210\/jc.2007-2063","article-title":"Ghrelin inhibits steroid biosynthesis by cultured granulosa\u2013lutein cells","volume":"93","author":"Viani","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2019.170233_bib0420","first-page":"875625","article-title":"Plasma ghrelin obesity and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels","author":"Pagotto","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2019.170233_bib0425","first-page":"26629","article-title":"Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome","author":"Gambineri","year":"2003","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.peptides.2019.170233_bib0430","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/09513590.2019.1597343","article-title":"Effects of kisspeptin on pathogenesis and energy metabolism in polycystic ovanian syndrome (PCOS)","volume":"35","author":"Wang","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.peptides.2019.170233_bib0435","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11892-011-0189-8","article-title":"Adipose tissue dysfunction in polycystic ovary syndrome","volume":"11","author":"Villa","year":"2011","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.peptides.2019.170233_bib0440","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2265.2001.01303.x","article-title":"Tissue insulin sensitivity and body weight in polycystic ovary syndrome","volume":"55","author":"Marsden","year":"2001","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"8","key":"10.1016\/j.peptides.2019.170233_bib0445","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s11695-018-3155-6","article-title":"Bariatric surgery improves hyperandrogenism, menstrual irregularities, and metabolic dysfunction among women with polycystic ovary syndrome (PCOS)","volume":"28","author":"Christ","year":"2018","journal-title":"Obes. Surg."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119302116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119302116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:28:12Z","timestamp":1759310892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978119302116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":89,"alternative-id":["S0196978119302116"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2019.170233","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging role of GIP and related gut hormones in fertility and PCOS","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2019.170233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170233"}}